Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate

ABSTRACT Aims/Hypothesis In diabetes haptoglobin (Hp) 2 vs Hp 1 allelic product is associated with cardiac and renal complications. Few studies report both Hp phenotype and Hp levels. In a Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial substudy we evaluated the Hp phenotype, H...

Full description

Bibliographic Details
Main Authors: Andrzej S. Januszewski, Hayden K. Young, Kwok‐Leung Ong, Liping Li, Rachel L. O’Connell, Timothy J. Lyons, Clare Kelly, Dessi P. Zaharieva, David R. Sullivan, Russell S. Scott, Anthony C. Keech, Alicia J. Jenkins, the FIELD Study Investigators
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Journal of Diabetes Investigation
Subjects:
Fenofibrate
Haptoglobin
Type 2 diabetes
Online Access:https://doi.org/10.1111/jdi.14290

Internet

https://doi.org/10.1111/jdi.14290

Similar Items